Omnicell Income from Continuous Operations 2010-2025 | OMCL
Omnicell income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Omnicell Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $13 |
| 2023 | $-20 |
| 2022 | $6 |
| 2021 | $78 |
| 2020 | $32 |
| 2019 | $61 |
| 2018 | $38 |
| 2017 | $31 |
| 2016 | $10 |
| 2015 | $31 |
| 2014 | $31 |
| 2013 | $24 |
| 2012 | $16 |
| 2011 | $10 |
| 2010 | $5 |
| 2009 | $0 |
| Omnicell Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $6 |
| 2025-03-31 | $-7 |
| 2024-12-31 | $16 |
| 2024-09-30 | $9 |
| 2024-06-30 | $4 |
| 2024-03-31 | $-16 |
| 2023-12-31 | $-14 |
| 2023-09-30 | $6 |
| 2023-06-30 | $3 |
| 2023-03-31 | $-15 |
| 2022-12-31 | $-28 |
| 2022-09-30 | $17 |
| 2022-06-30 | $9 |
| 2022-03-31 | $8 |
| 2021-12-31 | $14 |
| 2021-09-30 | $29 |
| 2021-06-30 | $20 |
| 2021-03-31 | $14 |
| 2020-12-31 | $16 |
| 2020-09-30 | $9 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $11 |
| 2019-12-31 | $22 |
| 2019-09-30 | $20 |
| 2019-06-30 | $16 |
| 2019-03-31 | $3 |
| 2018-12-31 | $15 |
| 2018-09-30 | $14 |
| 2018-06-30 | $7 |
| 2018-03-31 | $3 |
| 2017-12-31 | $31 |
| 2017-09-30 | $8 |
| 2017-06-30 | $2 |
| 2017-03-31 | $-10 |
| 2016-12-31 | $9 |
| 2016-09-30 | $2 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $0 |
| 2015-12-31 | $8 |
| 2015-09-30 | $8 |
| 2015-06-30 | $9 |
| 2015-03-31 | $6 |
| 2014-12-31 | $9 |
| 2014-09-30 | $7 |
| 2014-06-30 | $8 |
| 2014-03-31 | $6 |
| 2013-12-31 | $7 |
| 2013-09-30 | $8 |
| 2013-06-30 | $6 |
| 2013-03-31 | $3 |
| 2012-12-31 | $6 |
| 2012-09-30 | $7 |
| 2012-06-30 | $1 |
| 2012-03-31 | $2 |
| 2011-12-31 | $4 |
| 2011-09-30 | $3 |
| 2011-06-30 | $3 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $2 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $-2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.544B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.530B | 60.47 |
| Tempus AI (TEM) | United States | $13.989B | 0.00 |
| Doximity (DOCS) | United States | $12.688B | 56.45 |
| Hims & Hers Health (HIMS) | United States | $10.074B | 82.54 |
| IRhythm Technologies (IRTC) | United States | $5.433B | 0.00 |
| Hinge Health (HNGE) | United States | $4.516B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.839B | 41.74 |
| Privia Health (PRVA) | United States | $2.699B | 199.91 |
| Heartflow (HTFL) | $2.367B | 0.00 | |
| Enovis (ENOV) | United States | $1.797B | 9.50 |
| 10x Genomics (TXG) | United States | $1.780B | 0.00 |
| Phreesia (PHR) | United States | $1.770B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.446B | 63.10 |
| Clover Health Investments (CLOV) | United States | $1.399B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.128B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.469B | 140.00 |
| Butterfly Network (BFLY) | United States | $0.383B | 0.00 |
| Carlsmed (CARL) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 53.90 |
| Outset Medical (OM) | United States | $0.252B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.231B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.219B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.156B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.120B | 5.44 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |